European Archives - Page 673 of 1280 - European Medical Journal

Injectable Penicillin Not Recommended for High-risk Rheumatic Heart Disease

A recent study has revealed that the delivery of penicillin is important when treating high-risk patients with rheumatic heart disease…

Could Hip Dysplasia in Infants Be Predicted by Ultrasound?

A novel ultrasound technique could precisely predict which infants diagnosed with hip dysplasia will have a normal hip structure…

Novel Blood Test Combined with MRI in Prostate Cancer Screening

A new blood test alongside MRI could minimise the cost of prostate cancer screening, as well as the overdiagnosis of low-risk cancer…

Digital Necrosis in Multiple Myeloma

Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow…

EMJ Oncology 10 [Supplement 2] 2022 feature

EMJ Oncology 10 [Supplement 2] 2022

This article features interviews conducted with industry experts Lorenza Rimassa, Medical Oncology, Humanitas University and IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy, Arndt Vogel, Hannover Medical School, Germany, and Harpreet Wasan, Gastrointestinal Medical Oncology, Imperial College, Hammersmith Hospital, London, UK.

Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from the EADV 2021

The latest research on autoimmune skin disease has studied the efficacy and safety characterisation of guselkumab (GUS), a human monoclonal…

EMJ Dermatology 10 [Infographic Supplement 1] 2022 Feature Image

EMJ Dermatology 10 [Infographic Supplement 1] 2022

An infographic based on a satellite symposium from the 2021 European Society for Dermatological Research (ESDR) Annual Meeting delves into the IL-23 pathway and the management of PsO and PsA, the targeting of this pathway in the skin, and the detection and management of PsA from the perspective of both dermatologists and rheumatologists. Read here for an insight into this topic.

Diving Deep: Harnessing the Potential of the IL-23 Pathway

Strober began by summarising his opinion on the key characteristics of anti-IL-23 therapies that support their efficacy for inducing…

EMJ Dermatology 10 [Supplement 2] 2022

Presentations from the Virtual 30th European Academy of Dermatology and Venereology (EADV) Congress 2021 discussed the potential of targeting the IL-23 pathway as a biologic treatment for psoriatic arthritis (PsA) and psoriasis (PsO).

EMJ Oncology 10 [Supplement 2] 2022 feature

Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…